3-Dose Covid-19 Vaccine Protects Children Ages 6 Months To 5 years, Pfizer & BioNTech Say

podcast: CBS Baltimore

Three child-size doses of the Pfizer/BioNTech Covid-19 vaccine appeared to be safe and showed a strong immune response in children ages 6 months to 5 years, the companies said Monday. The vaccine makers said they will finish submitting the trial data to the US Food and Drug Administration this week.
Publicado con Parlarispa

Lista de episodios - [audio]